DekaBank Deutsche Girozentrale’s 10x Genomics TXG Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,027	Closed	-$65K	–	1351
2025 Q4	$65K	Hold	2,027	–	–	﹤0.01%	1299
2025 Q3	$23K	Hold	2,027	–	–	﹤0.01%	1362
2025 Q2	$24K	Hold	2,027	–	–	﹤0.01%	1371
2025 Q1	$18K	Hold	2,027	–	–	﹤0.01%	1377
2024 Q4	$28K	Hold	2,027	–	–	﹤0.01%	1392
2024 Q3	$45K	Hold	2,027	–	–	﹤0.01%	1373
2024 Q2	$39K	Hold	2,027	–	–	﹤0.01%	1408
2024 Q1	$74K	Hold	2,027	–	–	﹤0.01%	1307
2023 Q4	$116K	Hold	2,027	–	–	﹤0.01%	1306
2023 Q3	$84K	Sell	2,027 -27,973	-93%	-$1.46M	﹤0.01%	1332
2023 Q2	$1.7M	Hold	30,000	–	–	﹤0.01%	786
2023 Q1	$1.54M	Hold	30,000	–	–	﹤0.01%	777
2022 Q4	$1.09M	Sell	30,000 -7,500	-20%	-$245K	﹤0.01%	854
2022 Q3	$1.1M	Sell	37,500 -70,300	-65%	-$2.68M	﹤0.01%	852
2022 Q2	$4.89M	Buy	107,800 +67,113	+165%	+$3.48M	0.01%	540
2022 Q1	$3.13M	Buy	40,687 +8,638	+27%	+$756K	0.01%	656
2021 Q4	$4.62M	Sell	32,049 -13,330	-29%	-$2.04M	0.01%	587
2021 Q3	$6.61M	Buy	45,379 +38,505	+560%	+$6.61M	0.02%	474
2021 Q2	$1.37M	Buy	6,874 +3,362	+96%	+$608K	﹤0.01%	830
2021 Q1	$589K	Buy	3,512 +13	+0.4%	+$2.25K	﹤0.01%	999
2020 Q4	$496K	Buy	+3,499	New	+$508K	﹤0.01%	1022

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DekaBank Deutsche Girozentrale's TXG Position: Q1 2026 in Review

DekaBank Deutsche Girozentrale sold out of 10x Genomics (TXG) in Q1 2026, closing a stake of 2,027 shares — an estimated $65K sold.

DekaBank Deutsche Girozentrale first reported a position in TXG in Q4 2020 and held it in 21 quarters. The position peaked at $6.61M in Q3 2021. 332 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

DekaBank Deutsche Girozentrale reported no remaining 10x Genomics position as of Q1 2026 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 2,027 10x Genomics shares in Q1 2026, an estimated $65K.
DekaBank Deutsche Girozentrale first reported a position in 10x Genomics in Q4 2020 and held it in 21 quarters.
DekaBank Deutsche Girozentrale's 10x Genomics position peaked at $6.61M in Q3 2021.
332 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2026, filed 7 May 2026.